In general, this should occur regardless of the dose reported (Grade D). This referral should be guided by local poison center procedures. The grade of recommendation is in parentheses: 1) Patients with stated or suspected self-harm or who are the victims of a potentially malicious administration of a salicylate, should be referred to an emergency department immediately. Recommendations are in chronological order of likely clinical use. This guideline does not substitute for clinical judgment. The expert consensus panel recognizes that specific patient care decisions may be at variance with this guideline and are the prerogative of the patient and the health professionals providing care, considering all of the circumstances involved. This guideline is based on an assessment of current scientific and clinical information. The objective of this guideline is to assist poison center personnel in the appropriate out-of-hospital triage and initial out-of-hospital management of patients with a suspected exposure to salicylates by 1) describing the process by which a specialist in poison information should evaluate an exposure to salicylates, 2) identifying the key decision elements in managing cases of salicylate exposure, 3) providing clear and practical recommendations that reflect the current state of knowledge, and 4) identifying needs for research. The panel then made changes based on the secondary review comments. The entire panel discussed and refined the guideline before distribution to secondary reviewers for comment. The first draft of the guideline was created by the lead author. Relevant articles were abstracted by a trained physician researcher. ![]() ![]() An evidence-based expert consensus process was used to create the guideline. A guideline that determines the conditions for emergency department referral and pre-hospital care could potentially optimize patient outcome, avoid unnecessary emergency department visits, reduce health care costs, and reduce life disruption for patients and caregivers. poison center data for 2004 showed over 40,000 exposures to salicylate-containing products.
0 Comments
Leave a Reply. |